- Published on
Diagnostic Tests – Sentinel Node Evaluation
1. What Is Sentinel Node Evaluation?
Sentinel node evaluation, or sentinel lymph node biopsy (SLNB), is a diagnostic procedure used primarily in the management of breast cancer (and also melanoma). Its purpose is to determine whether cancer has begun to spread beyond the primary tumor into the regional lymph nodes. Because cancer metastasizes in an orderly fashion through lymphatic drainage, the sentinel node—the first lymph node that receives lymph flow from the tumor site—acts as an early indicator of metastatic spread. Examining this node helps determine staging, prognosis, and the need for further lymph node removal.
2. How Is Sentinel Node Evaluation Done?
The procedure involves injecting a tracer dye, radioactive substance, or both into the breast at or near the tumor or biopsy cavity during surgery. This material travels through the lymphatic system, and the first lymph node it reaches is identified as the sentinel node. The surgeon then removes this node and sends it for pathological analysis.
3. When Is Sentinel Node Evaluation the Correct Answer?
A sentinel node biopsy is indicated after a diagnosis of breast cancer has already been established through either needle biopsy or excisional biopsy. You should choose sentinel node evaluation in cases where the patient has:
At this point, SLNB becomes the next best step because it provides essential staging information and helps determine whether cancer has begun to spread to the lymph nodes. It is particularly valuable because it can replace the need for full axillary lymph node dissection in patients whose sentinel node is free of cancer, thereby reducing surgical complications while still providing accurate staging.
1. What Is Sentinel Node Evaluation?
Sentinel node evaluation, or sentinel lymph node biopsy (SLNB), is a diagnostic procedure used primarily in the management of breast cancer (and also melanoma). Its purpose is to determine whether cancer has begun to spread beyond the primary tumor into the regional lymph nodes. Because cancer metastasizes in an orderly fashion through lymphatic drainage, the sentinel node—the first lymph node that receives lymph flow from the tumor site—acts as an early indicator of metastatic spread. Examining this node helps determine staging, prognosis, and the need for further lymph node removal.
2. How Is Sentinel Node Evaluation Done?
The procedure involves injecting a tracer dye, radioactive substance, or both into the breast at or near the tumor or biopsy cavity during surgery. This material travels through the lymphatic system, and the first lymph node it reaches is identified as the sentinel node. The surgeon then removes this node and sends it for pathological analysis.
- If the sentinel node contains cancer cells, this indicates lymphatic spread, and a full axillary lymph node dissection may be performed to remove additional nodes.
- If the sentinel node is negative, it suggests that cancer has not yet metastasized regionally, and axillary dissection can be safely avoided, sparing the patient significant morbidity such as lymphedema.
3. When Is Sentinel Node Evaluation the Correct Answer?
A sentinel node biopsy is indicated after a diagnosis of breast cancer has already been established through either needle biopsy or excisional biopsy. You should choose sentinel node evaluation in cases where the patient has:
- An abnormal mammogram
- A breast mass that has been biopsied
- Confirmed invasive breast cancer
At this point, SLNB becomes the next best step because it provides essential staging information and helps determine whether cancer has begun to spread to the lymph nodes. It is particularly valuable because it can replace the need for full axillary lymph node dissection in patients whose sentinel node is free of cancer, thereby reducing surgical complications while still providing accurate staging.
0 Comments
